LLY
912.56
+0.99%↑
JNJ
240.05
+2.01%↑
ABBV
206.33
+0.73%↑
NVS
150.79
+1.38%↑
MRK
118.86
+2.37%↑
LLY
912.56
+0.99%↑
JNJ
240.05
+2.01%↑
ABBV
206.33
+0.73%↑
NVS
150.79
+1.38%↑
MRK
118.86
+2.37%↑
LLY
912.56
+0.99%↑
JNJ
240.05
+2.01%↑
ABBV
206.33
+0.73%↑
NVS
150.79
+1.38%↑
MRK
118.86
+2.37%↑
LLY
912.56
+0.99%↑
JNJ
240.05
+2.01%↑
ABBV
206.33
+0.73%↑
NVS
150.79
+1.38%↑
MRK
118.86
+2.37%↑
LLY
912.56
+0.99%↑
JNJ
240.05
+2.01%↑
ABBV
206.33
+0.73%↑
NVS
150.79
+1.38%↑
MRK
118.86
+2.37%↑
24h
Current
Min
4.91
Max
5.24
Recommendations | Neutral |
|---|---|
12 Months Forecast | +20.24% upside |
Next Earnings | 14 maj 2026 |
|---|
By Acuity
100%
0%
333 / 350 Ranking in Healthcare
By Trading Central
Confidence
Weak Bearish Evidence
7.245 / 7.64 Support & Resistance
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
12 sty 2026, 15:39 UTC
Atara Biotherapeutics Stock Falls After Surprise FDA Refusal to Approve Ebvallo
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 6 USD 20.24%
High 6 USD
Low 6 USD
Based on 1 Wall Street analysts offering 12 month price targets forAtara Biotherapeutics Inc - Dist in the last 3 months.
By TipRanks
Neutral
1 ratings
0
Buy
1
Hold
0
Sell
Based on 1 analysts giving stock ratings to Atara Biotherapeutics Inc - Dist in the past 3 months.
By Trading Central
Short Term
Weak Bearish Evidence
Recent bearish events outweigh bullish events.
Intermediate Term
Strong Bullish Evidence
Recent bullish events outweigh bearish events.
Long Term
Bearish Evidence
All events are bearish.
By Acuity
News Sentiment
Very Strong Bearish Evidence
Volatility
Below average
News Volume (RCV)
Above average
$